Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Pharmafocus Europe

March 12, 2007 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus

Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …
Feature

Merck lung cancer vaccine enters phase III trials

March 7, 2007 Research and Development

A therapeutic vaccine for the most common form of lung cancer has enrolled its first patient into global phase III …
News

Work begins on Eisai’s Knowledge Centre

March 7, 2007 Research and Development, Sales and Marketing

Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …
News

Prime Minister opens Amgen European R&D centre

March 2, 2007 Research and Development

Prime Minister Tony Blair has opened Amgen's new European Development Centre in Uxbridge, London.The centre is the Californian biotech company's …
News

New clinical trials network to boost patient recruitment in UK

March 2, 2007 Research and Development

Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …
News

Learning from Northwick Park

February 19, 2007 Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …
Feature

New HIV therapy to be fast-tracked

February 15, 2007 Research and Development

A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …
News

UK biotech consortium wins major grant for cutting-edge gene therapy

February 14, 2007 Research and Development

The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …
News

UK pharma and government launch new collaboration

February 14, 2007 Research and Development

A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …
News

New anti-clotting antibody enters trials

February 12, 2007 Research and Development, Sales and Marketing

European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …
News

Momentum growing at specialists Archimedes as lead enters phase III

February 9, 2007 Research and Development

Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …
News

Arrow purchase adds another string to AZ’s biotech bow

February 9, 2007 Research and Development

AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …
News

MorphoSys opens UK headquarters in Oxford

January 31, 2007 Research and Development

A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …
News

Vectura buys Innovata

January 22, 2007 Research and Development biotech, vectura

 Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …
News

Wellcome Trust issues first grants to encourage drug discovery

January 19, 2007 Research and Development

The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026